Consistent with effects mentioned above, HT treatment obviously weakened the expansion of atheroma lesions and improved the serum and hepatic lipid profile as well as ameliorated hepatic steatosis and inflammatory status in apoE−/− mice. The gene discussed is APOE; the disease is Hepatic steatosis.